N-[(4-氨基-2-甲基-5-嘧啶)甲基]- N-(2-氯乙基)脲

N-[(4-氨基-2-甲基-5-嘧啶)甲基]- N-(2-氯乙基)脲 基本信息

中文名称：

N-[(4-氨基-2-甲基-5-嘧啶)甲基]- N-(2-氯乙基)脲 

中文别名：

N-[(4-氨基-2-甲基-5-嘧啶)甲基]-n-(2-氯乙基)脲;
N-[(4-氨基-2-甲基-5-嘧啶)甲基]-N'-(2-氯乙基)脲;
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride (1:1);
Nimustine;
1-deoxy-1-(methylamino)-d-glucito-2-((2-methyl-3-(trifluoromethyl)phenyl)amino;
Flunixin meglumin;
Flunixin meglumine;
(r)-(-)-3-hydroxyguinuclidine hydrochloride;
(r)-(-)-3-hydroxyquinuclidine hcl;
(r)-(-)-3-hydroxyquinuclidine hydrochloride;
(3R)-1-azabicyclo[2.2.2]octan-3-ol hydrochloride;< 

英文名称：

Urea,N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N'-(2-chloroethyl)-

英文别名：

1-[(4-amino-2-methylpyrimidin-5-yl)methyl]-3-(2-chloroethyl)urea;
N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N'-(2-chloroethyl)urea;
Nimustine;
1-deoxy-1-(methylamino)-d-glucito-2-((2-methyl-3-(trifluoromethyl)phenyl)amino;
Flunixin meglumin;
Flunixin meglumine;
(r)-(-)-3-hydroxyguinuclidine hydrochloride;
(r)-(-)-3-hydroxyquinuclidine hcl;
(r)-(-)-3-hydroxyquinuclidine hydrochloride;
(3R)-1-azabicyclo[2.2.2]octan-3-ol hydrochloride;
(R)-3-Quinuclidinol hydrochloride;
NSC 293873;
O-Methyl (2-(2-methyl-5-nitroimidazol-1-yl)ethyl)thiocarbamate;
R 25831;
UNII-RH5KI819JG;
O-Methyl (2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)carbamothioate;
O-methyl [2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]thiocarbamate;
Carnidazole;
Bis(1,2,2,6,6-pentamethyl-4-piperidyl) sebacate;
(5alpha,6alpha)-3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-ol phosphate (salt);
(5alpha,6alpha)-3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-ol phosphate (2:2) hydrate (salt);
(5alpha,6alpha)-3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-ol 

CAS No.：

42471-43-2

分 子 式：

C₉H₁₄ClN₅O

分 子 量：

0

精确分子量：

243.08900

PSA：

92.93000

InChI：

InChI=1/C9H14ClN5O/c1-6-13-4-7(8(11)15-6)5-14-9(16)12-3-2-10/h4H,2-3,5H2,1H3,(H2,11,13,15)(H2,12,14,16)

分子结构式：

SDS：

查看

N-[(4-氨基-2-甲基-5-嘧啶)甲基]- N-(2-氯乙基)脲 物化性质

N-[(4-氨基-2-甲基-5-嘧啶)甲基]- N-(2-氯乙基)脲 下游产品